Prediction of short- and medium-term efficacy of biosimilar infliximab therapy. Do trough levels and antidrug antibody levels or clinical and biochemical markers play a more important role?

Gönczi, Lóránt, Végh, Zsuzsanna, Golovics, Petra Anna, Rutka, Mariann, Gecse, Krisztina Barbara, Bor, Renáta, Farkas, Klaudia, Szamosi, Tamás, Bene, László, Gasztonyi, Beáta, Kristóf, Tünde, Lakatos, László, Miheller, Pál, Palatka, Károly, Papp, Mária: Prediction of short- and medium-term efficacy of biosimilar infliximab therapy. Do trough levels and antidrug antibody levels or clinical and biochemical markers play a more important role?
JOURNAL OF CROHNS & COLITIS, 11 (6). pp. 697-705. ISSN 1873-9946 (2017)

[img] Text
3140312_Gonczi.pdf - Published Version
Korlátozott. Registered users only

Download (312kB) | Request a copy
Item Type: Article
Szerzők száma: 25
Journal or Publication Title: JOURNAL OF CROHNS & COLITIS
Date: 2017
Volume: 11
Number: 6
Page Range: pp. 697-705
ISSN: 1873-9946
Faculty: Faculty of Medicine
Institution: Szegedi Tudományegyetem
MTMT id: 3140312
DOI id: https://doi.org/10.1093/ecco-jcc/jjw203
Date Deposited: 2017. Sep. 28. 13:04
Last Modified: 2020. Feb. 14. 11:47
URI: http://publicatio.bibl.u-szeged.hu/id/eprint/12011
Web of Science® Times Cited: 29 View citing articles in Web of Science®

Actions (login required)

View Item View Item

Downloads

Downloads per month over past year